Market Intelligence Dossier: Executive insider transaction patterns and SEC Form 4 filing history for Actinium Pharmaceuticals, Inc. (ATNM) [Catalyst Tracker]
Market Intelligence Dossier: Executive insider transaction patterns and SEC Form 4 filing history for Actinium Pharmaceuticals, Inc. (ATNM) [Catalyst Tracker]
Corporate governance tracking and executive insider sentiment analytics for Actinium Pharmaceuticals, Inc. (ticker ATNM) aggregates official SEC Form 4 insider filings submitted by officers, directors, and beneficial owners holding greater than 10% equity. Independent forensic analysis examines transaction timing, direct share ownership adjustments, and option exercise executions relative to historical enterprise performance, offering a transparent window into internal leadership confidence. Cross-domain market intelligence verifies historical trading patterns against public information disclosures, highlighting transparency and governance metrics.
Verified Quantitative Data
| Metric | Value |
|---|---|
| Is Cross | false |
| Has Whale | true |
| Has Congress | false |
| Has Contract | false |
| Darkpool Ratio | 0.6911 |
Full trading intelligence, federal contract history and congressional flow for ATNM.
Primary Source Record
This fact is compiled from public federal disclosure records. Explore the underlying dataset on the Federal Contract Explorer and the Capitol Trades leaderboard.
Data intelligence from public filings — not investment advice.